OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

Hoag recently completed its 30,000th robotic-assisted surgery, a significant milestone for the first health system in Orange County to adopt the technology twenty years ago. It is one of a few medical ...

Hepatocellular carcinoma, a type of liver cancer, is the sixth most common cancer worldwide and the third leading cause of ...

Eko Health announced today that the American Medical Association issued a Category III CPT code for its Sensora platform.

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

The Samsung Galaxy Ring is a debut for the brand, but also an extension in its lineup of wearables. It can track certain ...

The Fibrosis-4 Index (FIB-4) is used to identify adults who don’t have viral ... “Thus, current guidelines focusing on early ...

The solid electrolyte interface (SEI) in lithium-ion (Li-ion) batteries is essential for calculating a battery’s capacity and ...

Fourth Frontier has achieved a crucial milestone with the FDA's clearance of the Frontier X Plus, a single-lead ECG monitor. Positioned to enhance heart health monitoring, this wearable device ...

Atrial arrhythmias were found in 26% of patients with sickle cell disease (SCD), with a significant association with stroke history. Early detection and treatment of atrial arrhythmias may help ...

Fourth Frontier, a medical technology company based out of New York and Bangalore, announced the 510(k) clearance of the ...